NASDAQ:MGEN
Delisted
Miragen Therapeutics, Inc. Stock News
$17.64
+0 (+0%)
At Close: Aug 17, 2022
miRagen Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
02:00pm, Friday, 07'th Feb 2020
BOULDER, Colo., Feb. 07, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, to
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
miRagen Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
09:03pm, Thursday, 06'th Feb 2020
BOULDER, Colo., Feb. 06, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, to
TWTR, ZNGA among premarket gainers
02:13pm, Thursday, 06'th Feb 2020
Unisys (NYSE:UIS) +39% as Unisys federal unit being acquired by Science Applications International.Myomo (NYSEMKT:MYO) +32%.China Xiangtai Food (NASDAQ:PLIN) +26% on announcing 300% supermarket sale
Company News for Jan 31, 2020
03:41pm, Friday, 31'st Jan 2020
Companies In The News Are: BGG, INO, MDLZ, MGEN
Company News for Jan 31, 2020
03:41pm, Friday, 31'st Jan 2020
Companies In The News Are: BGG, INO, MDLZ, MGEN
The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO
02:09pm, Friday, 31'st Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (
miRagen Therapeutics Announces Positive Data for Cobomarsen in Adult T-Cell Leukemia/lymphoma Patients With Residual Disease
12:00pm, Thursday, 30'th Jan 2020
BOULDER, Colo., Jan. 30, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on
The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes
03:23pm, Sunday, 26'th Jan 2020
Biotech stocks haven't seen much of a momentum thus far in the new year amid a lack of meaningful catalysts. The bygone week saw two FDA approvals: Horizon Therapeutics PLC's (NASDAQ: HZNP ) thyroid
miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma at Two Upcoming Conferences
01:00pm, Thursday, 23'rd Jan 2020
BOULDER, Colo., Jan. 23, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 12.) Allergan plc (NYSE: AGN ) Amgen, Inc.
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
12:38pm, Thursday, 12'th Dec 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Thera
miRagen Announces Major Changes to Company’s Strategy
09:05pm, Wednesday, 11'th Dec 2019
BOULDER, Colo., Dec. 11, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus o
miRagen to Present at the Evercore ISI HealthCONx Conference 2019
01:00pm, Tuesday, 26'th Nov 2019
BOULDER, Colo., Nov. 26, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on
A Review Of 2019 iGaming Acquisitions | FinSMEs
11:01pm, Thursday, 24'th Oct 2019
Indeed, 2019 has seen some of the most exciting acquisitions in igaming for years, with major brands like Rank, 888 and William Hill making significant buys